Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Leire Recalde Percaz"'
Autor:
Núria Moragas, Patricia Fernandez-Nogueira, Leire Recalde-Percaz, Jamie L. Inman, Anna López-Plana, Helga Bergholtz, Aleix Noguera-Castells, Pedro J. del Burgo, Xieng Chen, Therese Sorlie, Pere Gascón, Paloma Bragado, Mina Bissell, Neus Carbó, Gemma Fuster
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-23 (2024)
Abstract Background A better understanding of ductal carcinoma in situ (DCIS) is urgently needed to identify these preinvasive lesions as distinct clinical entities. Semaphorin 3F (SEMA3F) is a soluble axonal guidance molecule, and its coreceptors Ne
Externí odkaz:
https://doaj.org/article/a7b86ab5f4424b1c832aa95928fa8976
Autor:
Arantzazu Zubeldia-Plazaola, Leire Recalde-Percaz, Núria Moragas, Mireia Alcaraz, Xieng Chen, Mario Mancino, Patricia Fernández-Nogueira, Miquel Prats de Puig, Flavia Guzman, Aleix Noguera-Castells, Anna López-Plana, Estel Enreig, Neus Carbó, Vanessa Almendro, Pedro Gascón, Paloma Bragado, Gemma Fuster
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-16 (2018)
Abstract Background The microenvironment and stress factors like glucocorticoids have a strong influence on breast cancer progression but their role in the first stages of breast cancer and, particularly, in myoepithelial cell regulation remains uncl
Externí odkaz:
https://doaj.org/article/09270c8358e54183a6b3aa8944386a95
Autor:
Paloma Bragado, Pere Gascon, Joan Albanell, Ana Lluch, Ana Rovira, Elisabet Ametller, Raul Alonso, Núria Moragas, Leire Recalde-Percaz, Laia Serrano, L. Alex Gaither, Anke Bill, Aleix Noguera-Castells, Federico Rojo, Silvia Menéndez, Estel Enreig, Vanesa Almendro, Patricia Jauregui, Anna López-Plana, Gemma Fuster, Mario Mancino, Patricia Fernández-Nogueira
Fibroblast effect on HER2 activation and HER2-targeted therapies sensitivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09231ac70523ec6b34a3bc7388d36ca9
https://doi.org/10.1158/1078-0432.22473389
https://doi.org/10.1158/1078-0432.22473389
Autor:
Paloma Bragado, Pere Gascon, Joan Albanell, Ana Lluch, Ana Rovira, Elisabet Ametller, Raul Alonso, Núria Moragas, Leire Recalde-Percaz, Laia Serrano, L. Alex Gaither, Anke Bill, Aleix Noguera-Castells, Federico Rojo, Silvia Menéndez, Estel Enreig, Vanesa Almendro, Patricia Jauregui, Anna López-Plana, Gemma Fuster, Mario Mancino, Patricia Fernández-Nogueira
Purpose:Despite the therapeutic success of existing HER2-targeted therapies, tumors invariably relapse. This study aimed at identifying new mechanisms responsible for HER2-targeted therapy resistance.Experimental Design:We have used a platform of HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75503a5e3c93200695c9cee440396104
https://doi.org/10.1158/1078-0432.c.6528494
https://doi.org/10.1158/1078-0432.c.6528494
Autor:
Paloma Bragado, Pere Gascon, Joan Albanell, Ana Lluch, Ana Rovira, Elisabet Ametller, Raul Alonso, Núria Moragas, Leire Recalde-Percaz, Laia Serrano, L. Alex Gaither, Anke Bill, Aleix Noguera-Castells, Federico Rojo, Silvia Menéndez, Estel Enreig, Vanesa Almendro, Patricia Jauregui, Anna López-Plana, Gemma Fuster, Mario Mancino, Patricia Fernández-Nogueira
Supplementary Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::153a4e30a5aa46b033fbfa300e7a966b
https://doi.org/10.1158/1078-0432.22473374.v1
https://doi.org/10.1158/1078-0432.22473374.v1
Autor:
Paloma Bragado, Pere Gascon, Joan Albanell, Ana Lluch, Ana Rovira, Elisabet Ametller, Raul Alonso, Núria Moragas, Leire Recalde-Percaz, Laia Serrano, L. Alex Gaither, Anke Bill, Aleix Noguera-Castells, Federico Rojo, Silvia Menéndez, Estel Enreig, Vanesa Almendro, Patricia Jauregui, Anna López-Plana, Gemma Fuster, Mario Mancino, Patricia Fernández-Nogueira
File describing the supplementary material and methods and the table for the antibodies and drugs used for treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ce7a3aa0167e9564d668793e69fb08
https://doi.org/10.1158/1078-0432.22473371.v1
https://doi.org/10.1158/1078-0432.22473371.v1
Autor:
Leire Recalde-Percaz, Patricia Jauregui, Anna López-Plana, Patricia Fernandéz-Nogueira, Minerva Iniesta-González, Sara Manzano, Raul Alonso, Aleix Noguera-Castells, Nuria Moragas, Cristina Baquero, Maria Rodrigo-Faus, Nerea Palao, Erica Dalla, Francesc Xavier Aviles-Jurado, Isabel Vilaseca, Mercedes Camacho, Xavier Leon-Vintro, Gemma Fuster, Jordi Alcaraz, Julio Aguirre-Ghiso, Pere Gascón, Álvaro Gutierrez-Uzquiza, Almudena Porras, Neus Carbo, Paloma Bragado
Metastasis is the main cause of death from solid tumours and, therefore, identifying the mechanisms that govern metastatic growth poses a major biomedical challenge. We and others have contributed to demonstrate that tumour microenvironment (TME) sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b50ab09281c91f60bb11817aabd1805b
https://doi.org/10.21203/rs.3.rs-1956933/v1
https://doi.org/10.21203/rs.3.rs-1956933/v1
Autor:
Patricia Jauregui, Aleix Noguera-Castells, Raul Alonso, Silvia Menendez, Laia Serrano, Elisabet Ametller, Ana Lluch, L. Alex Gaither, Federico Rojo, Paloma Bragado, Pere Gascón, Leire Recalde-Percaz, Mario Mancino, Ana Rovira, Estel Enreig, Núria Moragas, Joan Albanell, Patricia Fernández-Nogueira, Vanessa Almendro, Anke Bill, Gemma Fuster, Anna López-Plana
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Purpose:Despite the therapeutic success of existing HER2-targeted therapies, tumors invariably relapse. This study aimed at identifying new mechanisms responsible for HER2-targeted therapy resistance.Experimental Design:We have used a platform of HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e227e565ba327bbbd44f395147ae2e89
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4333
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4333
Autor:
Aleix Noguera-Castells, Elisabet Megías-Roda, Gemma Fuster, Anna López-Plana, Tatiana Erazo, Pau Muñoz-Guardiola, Héctor Pérez-Montoyo, Carles Domenech, Patricia Fernández-Nogueira, Jose Alfon, Pere Gascón, Paloma Bragado, Marc Yeste-Velasco, Leire Recalde-Percaz, Teresa Moran, Ernest Nadal, Mariana Gomez-Ferreria, Patricia Jauregui, Mario Mancino, Jose M. Lizcano, Elisabet Ametller, Sonia Solé-Sánchez, Núria Moragas‐Garcia
Publikováno v:
International journal of cancerReferences. 147(4)
Around 40% of newly diagnosed lung cancer patients are Stage IV, where the improvement of survival and reduction of disease-related adverse events is the main goal for oncologists. In this scenario, we present preclinical evidence supporting the use
Autor:
Patricia Jauregui, Núria Moragas, Paloma Bragado, Leire Recalde-Percaz, Aleix Noguera-Castells, Estel Enreig, Pedro Gascón, Vanessa Almendro, Mario Mancino, Patricia Fernández-Nogueira, Gemma Fuster, Anna López-Plana, Neus Carbó
Publikováno v:
Cancer letters. 424
Histamine receptor 1 (HRH1) belongs to the rhodopsin-like G-protein-coupled receptor family. Its activation by histamine triggers cell proliferation, embryonic development, and tumor growth. We recently established that HRH1 is up-regulated in basal